Blindness: Clinical Trials

2 trials for Blindness, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Unknown 2
Phase 21Unknown 1

Follow Blindness: new trials by email Literature Review of Blindness trials Research Report on Blindness

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Open-label, Dose Escalation and Double-masked, Randomized, Controlled Trial Evaluating Safety and Tolerability of Sepofarsen in Children (<8 Years of Age) With LCA10 Caused by Mutations in the CEP290 Gene.
sepofarsen - Leber Congenital Amaurosis 10, Blindness
Phase 2 / Phase 3UnknownProQR Therapeutics152021-03-232022-03-25
Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
tasimelteon - Non 24 Hour Sleep Wake Disorder
Phase 3UnknownVanda Pharmaceuticals1402010-10-282024-04-03

Narrower conditions

Eye Diseases (2)  ·  Chronobiology Disorders (1)  ·  Dyssomnias (1)  ·  Eye Abnormalities (1)  ·  Leber Congenital Amaurosis (1)  ·  Leber Congenital Amaurosis 10 (1)  ·  Meckel Syndrome, Type 4 (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Retinal Degeneration (1)  ·  Retinal Diseases (1)  ·  Retinal Dystrophies (1)  ·  Sensation Disorders (1)  ·  Sleep Disorders, Circadian Rhythm (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (2)  ·  Signs and Symptoms (2)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Eye Diseases, Hereditary (1)  ·  Mental Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Occupational Diseases (1)  ·  Sensation Disorders (1)  ·  Vision Disorders (1)

Interventions

tasimelteon (1)

Sponsors

ProQR Therapeutics (1)  ·  Vanda Pharmaceuticals (1)

Countries

Belgium (1)  ·  Brazil (1)  ·  Canada (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  United Kingdom (1)